Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.6B | 2.6B | 2.6B |
Cost of revenue | 776M | 723M | 718M | 727M |
Gross profit | 2.0B | 1.9B | 1.9B | 1.8B |
Operating expense | ||||
Research & development | 421M | 362M | 375M | 374M |
Selling general and admin | 957M | 797M | 850M | 786M |
Other operating expenses | 86M | 81M | 87M | 89M |
Operating income | 484M | 616M | 543M | 595M |
Non operating interest income | ||||
Income | 64M | 77M | 76M | 72M |
Expense | 62M | 61M | 65M | 63M |
Other income expense | -9M | 2M | 63M | 193M |
Pretax income | 477M | 634M | 617M | 797M |
Tax provision | 108M | 129M | -63M | 161M |
Net income | 368M | 503M | 679M | 634M |
Basic EPS | 0.8 | 1.1 | 1.4 | 1.3 |
Diluted EPS | 0.8 | 1.1 | 1.4 | 1.3 |
Basic average shares | 461M | 467M | 477M | 487M |
Diluted average shares | 470M | 475M | 485M | 494M |
EBITDA | 655M | 772M | 698M | 759M |
Net income from continuing op. | 369M | 505M | 680M | 636M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |